(MENAFN- Baystreet) 01:41 PM EST - Doseology Sciences Inc : Announces the appointment of Patrick W. Sills as Strategic Go-to-Market Advisor. Mr. Sills is an experienced commercial strategist with over 15 years of leadership in the nicotine and functional CPG sectors. His career includes senior roles with Philip Morris International and Fontem Ventures B.V., where he led initiatives in go-to-market strategy, product commercialization, and regulatory compliance within the nicotine pouch and reduced-risk product categories. Mr. Sills will support Doseology's commercialization strategy, focusing on product positioning, distribution, regulatory considerations, and market expansion opportunities within the Company's oral stimulant portfolio. Doseology Sciences Inc shares C are trading up one cent at $1.50.

Full Press Release:

MENAFN17072025000212011056ID1109815856